MYC and X-linked retinoschisis: Dyka and Molday previously evaluated the protein assembly and co-expression of RS1 wildtype and missense variants together with myc-tagged wildtype RS1 genes (i.e., transgene) in an in vitro study to determine the potential effect of gene therapy in carriers of X-linked retinoschisis [39].